387 related articles for article (PubMed ID: 20614263)
1. p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma.
McHugh JB; Hoschar AP; Dvorakova M; Parwani AV; Barnes EL; Seethala RR
Head Neck Pathol; 2007 Dec; 1(2):123-31. PubMed ID: 20614263
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
Ozolek JA; Bastacky SI; Myers EN; Hunt JL
Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
[TBL] [Abstract][Full Text] [Related]
3. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
Geramizadeh B; Ravanshad M; Rahsaz M
Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
[TBL] [Abstract][Full Text] [Related]
5. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma.
Wang HY; Mills SE
Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088
[TBL] [Abstract][Full Text] [Related]
6. BSND is a Novel Immunohistochemical Marker for Oncocytic Salivary Gland Tumors.
Shinmura K; Kato H; Kawanishi Y; Kamo T; Inoue Y; Yoshimura K; Sugiyama K; Misawa K; Hosokawa S; Mineta H; Sugimura H
Pathol Oncol Res; 2018 Apr; 24(2):439-444. PubMed ID: 28470573
[TBL] [Abstract][Full Text] [Related]
7. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms.
Avery AK; Beckstead J; Renshaw AA; Corless CL
Am J Surg Pathol; 2000 Feb; 24(2):203-10. PubMed ID: 10680888
[TBL] [Abstract][Full Text] [Related]
8. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN
Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
[TBL] [Abstract][Full Text] [Related]
9. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.
Jain S; Roy S; Amin M; Acquafondata M; Yin M; Laframboise W; Bastacky S; Pantanowitz L; Dhir R; Parwani A
Am J Surg Pathol; 2013 Dec; 37(12):1824-30. PubMed ID: 24225843
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis.
Liu L; Qian J; Singh H; Meiers I; Zhou X; Bostwick DG
Arch Pathol Lab Med; 2007 Aug; 131(8):1290-7. PubMed ID: 17683191
[TBL] [Abstract][Full Text] [Related]
11. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
12. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
[TBL] [Abstract][Full Text] [Related]
13. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
[TBL] [Abstract][Full Text] [Related]
14. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma.
Kuroda N; Kanomata N; Yamaguchi T; Imamura Y; Ohe C; Sakaida N; Hes O; Michal M; Shuin T; Lee GH
Med Mol Morphol; 2011 Jun; 44(2):111-5. PubMed ID: 21717314
[TBL] [Abstract][Full Text] [Related]
16. Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up.
Alderman MA; Daignault S; Wolf JS; Palapattu GS; Weizer AZ; Hafez KS; Kunju LP; Wu AJ
Hum Pathol; 2016 Sep; 55():1-10. PubMed ID: 27085554
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis between monomorphic clear cell adenocarcinoma of salivary glands and renal (clear) cell carcinoma.
Rezende RB; Drachenberg CB; Kumar D; Blanchaert R; Ord RA; Ioffe OB; Papadimitriou JC
Am J Surg Pathol; 1999 Dec; 23(12):1532-8. PubMed ID: 10584707
[TBL] [Abstract][Full Text] [Related]
18. Oncocytic papillary renal cell carcinoma with solid architecture: mimic of renal oncocytoma.
Mai KT; Kohler DM; Robertson SJ; Belanger EC; Marginean EC
Pathol Int; 2008 Mar; 58(3):164-8. PubMed ID: 18251779
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
Pan CC; Chen PC; Ho DM
Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
[TBL] [Abstract][Full Text] [Related]
20. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]